BioPorto Valuation
| THOXF Stock | USD 0.29 0.00 0.00% |
BioPorto seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of BioPorto AS from analyzing the firm fundamentals such as Profit Margin of (2.50) %, current valuation of 106.91 M, and Return On Equity of -0.88 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioPorto's price fluctuation is very steady at this time. Calculation of the real value of BioPorto AS is based on 3 months time horizon. Increasing BioPorto's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioPorto pink sheet is determined by what a typical buyer is willing to pay for full or partial control of BioPorto AS. Since BioPorto is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioPorto Pink Sheet. However, BioPorto's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.29 | Real 0.24 | Hype 0.29 |
The real value of BioPorto Pink Sheet, also known as its intrinsic value, is the underlying worth of BioPorto AS Company, which is reflected in its stock price. It is based on BioPorto's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioPorto's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioPorto AS helps investors to forecast how BioPorto pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioPorto more accurately as focusing exclusively on BioPorto's fundamentals will not take into account other important factors: BioPorto Total Value Analysis
BioPorto AS is at this time anticipated to have takeover price of 106.91 M with market capitalization of 121.23 M, debt of 10.42 M, and cash on hands of 86.72 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioPorto fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
106.91 M | 121.23 M | 10.42 M | 86.72 M |
BioPorto Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. BioPorto AS had not issued any dividends in recent years. Based on the analysis of BioPorto's profitability, liquidity, and operating efficiency, BioPorto AS is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.BioPorto Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioPorto has an asset utilization ratio of 29.85 percent. This implies that the Company is making $0.3 for each dollar of assets. An increasing asset utilization means that BioPorto AS is more efficient with each dollar of assets it utilizes for everyday operations.BioPorto Ownership Allocation
BioPorto holds a total of 334.68 Million outstanding shares. BioPorto AS shows 19.84 percent of its outstanding shares held by insiders and 8.6 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioPorto Profitability Analysis
The company reported the revenue of 24.25 M. Net Loss for the year was (57.11 M) with profit before overhead, payroll, taxes, and interest of 15.04 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioPorto's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioPorto and how it compares across the competition.
About BioPorto Valuation
The pink sheet valuation mechanism determines BioPorto's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioPorto. We calculate exposure to BioPorto's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioPorto's related companies.BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.
8 Steps to conduct BioPorto's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioPorto's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioPorto's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioPorto's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioPorto's revenue streams: Identify BioPorto's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioPorto's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioPorto's growth potential: Evaluate BioPorto's management, business model, and growth potential.
- Determine BioPorto's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioPorto's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioPorto Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioPorto does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 267.7 M | |
| Retained Earnings | -221.7 M |
Complementary Tools for BioPorto Pink Sheet analysis
When running BioPorto's price analysis, check to measure BioPorto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioPorto is operating at the current time. Most of BioPorto's value examination focuses on studying past and present price action to predict the probability of BioPorto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioPorto's price. Additionally, you may evaluate how the addition of BioPorto to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |